Riskpilot← Back to searchSign inGet full accessNORDIC BIOSITE ApS
APSActiveCVR 30711572Landgreven 3, st. thHospital activities · NACE 8610Est. 20073 employees
Revenue 2024
DKK 6,6M
+49% vs 2023
EBITDA margin
23.5%
-51% vs 2023
Equity ratio
49.8%
Financial strength
Net profit 2024
DKK 1,2M
-51% vs 2023
| Revenue | DKK 6,6M | +49% |
| EBITDA | DKK 1,5M | -51% |
| Net profit | DKK 1,2M | -51% |
| Total assets | DKK 4,2M | -29% |
| Equity | DKK 2,1M | -38% |
| Employees | 3 | — |
Legal name
NORDIC BIOSITE ApS
CVR number
30711572
Legal form
Anpartsselskab
NACE code
8610 · Hospital activities
Founded
22. juni 2007
Share capital
DKK 125.000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede bestyrelse eller af direktøren alene eller af formanden for bestyrelsen alene.
Company purpose
Selskabets formål er at drive handel og industri.
Address
Landgreven 3, st. th
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.225 | 1.603 | 1.754 | 2.033 | 2.342 | 17.976 | 2.953 | 3.098 | 14.464 | 4.086 | 4.059 | 4.413 | 6.583 |
| Staff expenses | -1.072 | -1.352 | -1.657 | -1.666 | -1.644 | -1.411 | -1.727 | -1.416 | -2.357 | -2.506 | -1.791 | -1.243 | -5.034 |
| EBITDA | 153 | 251 | 97 | 367 | 699 | 1.133 | 1.226 | 1.683 | 12.107 | 1.580 | 2.268 | 3.170 | 1.549 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 153 | 251 | 97 | 367 | 699 | 1.133 | 1.226 | 1.683 | 12.107 | 1.580 | 2.268 | 3.170 | 1.549 |
| Net financials | -1 | -13 | 0 | -5 | 1 | -4 | -12 | -31 | -192 | -21 | -7 | -6 | -1 |
| Profit before tax | 152 | 239 | 98 | 362 | 700 | 1.129 | 1.213 | 1.652 | 11.915 | 1.558 | 2.261 | 3.164 | 1.547 |
| Tax | 40 | 63 | 24 | 86 | 154 | 249 | 268 | 368 | 2.646 | 345 | 495 | 697 | 342 |
| Net profit | 113 | 176 | 73 | 276 | 546 | 880 | 945 | 1.284 | 9.269 | 1.213 | 1.766 | 2.467 | 1.206 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1.782 | 2.067 | 2.118 | 3.219 | 3.698 | 4.587 | 4.009 | 3.473 | 16.642 | 3.840 | 5.953 | 5.936 | 4.190 |
| Equity | 387 | 313 | 386 | 662 | 1.208 | 1.088 | 1.073 | 1.417 | 9.686 | 2.400 | 2.416 | 3.382 | 2.088 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 50 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1.395 | 1.754 | 1.732 | 2.556 | 2.490 | 3.499 | 2.936 | 2.006 | 6.956 | 1.440 | 3.537 | 2.553 | 2.102 |
| Total debt | 1.395 | 1.754 | 1.732 | 2.556 | 2.490 | 3.499 | 2.936 | 2.056 | 6.956 | 1.440 | 3.537 | 2.553 | 2.102 |
EBITDA margin
23.5%
This company
15.8%
Market median
+49% vs market
20122024
Equity ratio
49.8%
This company
38.2%
Market median
+30% vs market
20122024
Return on equity
57.7%
This company
18.4%
Market median
+214% vs market
20122024
Net profit margin
18.3%
This company
8.1%
Market median
+126% vs market
20122024
Asset turnover
1.57×
This company
1.12×
Market median
+40% vs market
20122024
Debt / equity
1.01×
This company
0.62×
Market median
-63% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SS Management | Management | 2025 | — | — |
SS Management | Management | 2023 | — | — |
CE Management | Management | 2022 | — | — |
NB Founder | Founder | 2007 | — | — |
YD Management | Management | 2007 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2024 | — | — | |
| Chairman | 2018 | — | — | |
| Chairman | 2007 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2014 | — | — | |
| Chairman | 2020 | — | — | |
| Chairman | 2011 | — | — | |
| Board of Directors | 2007 | — | — | |
| Board of Directors | 2011 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2007 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NORDIC BIOSITE ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sara Sadi Varnam Khasti | Management | 0 companies |
| Sune Schmølker | Management | 0 companies |
| Camilla Eva Duborn | Management | 0 companies |
| Nordic Biosite AB | Founder | 0 companies |
| Yvonne Diana Zar | Management | 0 companies |
| John Philip Bergquist | Chairman | 0 companies |
| Magnus Åke Lundberg | Chairman | 0 companies |
| Carl Mikael Zar | Chairman | 0 companies |
| Lars Olof Erhard Gisterå | Chairman | 0 companies |
| Eva Veronica Zar Öhrn | Board of Directors | 0 companies |
| Wilhelmus Catharina Martinus van Hamond | Chairman | 0 companies |
| Lars Peter Bräutigam | Chairman | 0 companies |
| Per-Axel Goran Axelsson | Board of Directors | 0 companies |
| Lars Gunnar Björk | Board of Directors | 0 companies |